4.7 Review

The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma

期刊

FRONTIERS IN PHARMACOLOGY
卷 14, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2023.1270425

关键词

hepatocellular carcinoma; noncoding RNA; epithelial-mesenchymal transition; chemoresistance; exosomes

向作者/读者索取更多资源

Hepatocellular carcinoma (HCC) is a major global health problem and the leading cause of cancer-related deaths, especially in advanced stages with limited treatment options. Tumor resistance in HCC is closely associated with the activation and reversal of the EMT phenomenon, which are modulated by noncoding RNAs (ncRNAs). ncRNAs, circulating in the tumor microenvironment encapsulated in exosomes, play significant roles as both tumor suppressors and oncogenic molecules, controlling the malignant potential of HCC cells. This review highlights recent advances in ncRNAs related to EMT and categorizes the described mechanisms as direct and indirect for better summarization, and discusses the regulatory mechanisms of exosomal ncRNAs in EMT-HCC via intercellular communication pathways.
Hepatocellular carcinoma (HCC) remains a major health problem worldwide, being the leading cause of cancer-related deaths, with limited treatment options, especially in its advanced stages. Tumor resistance is closely associated with the activation of the EMT phenomenon and its reversal, being modulated by different molecules, including noncoding RNAs (ncRNAs). Noncoding RNAs have the potential to function as both tumor suppressors and oncogenic molecules, controlling the malignant potential of HCC cells. Basically, these molecules circulate in the tumor microenvironment, encapsulated in exosomes. Their impact on cell biology is more significant than originally expected, which makes related research rather complex. The temporal and spatial expression patterns, precise roles and mechanisms of specific ncRNAs encapsulated in exosomes remain primarily unknown in different stages of the disease. This review aims to highlight the recent advances in ncRNAs related to EMT and classifies the described mechanism as direct and indirect, for a better summarization. Moreover, we provide an overview of current research on the role of ncRNAs in several drug resistance-related pathways, including the emergence of resistance to sorafenib, doxorubicin, cisplatin and paclitaxel therapy. Nevertheless, we comprehensively discuss the underlying regulatory mechanisms of exosomal ncRNAs in EMT-HCC via intercellular communication pathways.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据